streetlab-vision’s Post

🔬💡 Dr. David Eichenbaum discusses the significant benchmarks in visual acuity improvements that could change treatment approaches for wet macular degeneration. He emphasizes that an improvement of five or six letters could lead to a straightforward adoption of new treatments, providing a clear benefit to patients. The key is achieving a balance where the benefits justify additional treatments. Tune in as we explore how these clinical outcomes could potentially set new standards in ophthalmology. #ClinicalTrials #Ophthalmology #PatientCare RIWC24: Retina International World Congress 2024

One of the ways to stay ahead in ophthalmology clinical research is by keeping up with the latest NEI findings. At True North, we leverage this knowledge to design more effective trials. What recent eye research excites you? Share below. #eyeinnovation #clinicalresearch #contractresearchorganization  National Eye Institute (NEI)

February is #AMDAwarenessMonth—a time to call attention to #AMD and other #ophthalmic conditions that can lead to visual impairment. Read our recently published research that utilizes #RWD from the American Academy of Ophthalmology IRISⓇ Registry (Intelligent Research in Sight) to investigate patterns of #ophthalmic imaging among vitreoretinal specialists for patients with #nAMD: https://hubs.la/Q02jsYlV0 #AMDAwarenessMonth #AMD #rwd

🌟 Dive into the insights of Dr. Anat Loewenstein as she discusses the findings of the Barometer Study - research made possible with the support of Bayer | Ophthalmology - a global survey aimed at understanding patient needs and healthcare practitioner awareness in ophthalmology. Discover the surprising revelations about clinic accessibility, staff knowledge gaps, and patient communication. Dr. Loewenstein's discussion sheds light on crucial areas needing attention in eye care, sparking conversations on how to enhance patient experience and staff education. Join us for this eye-opening session! #COPHY2024 #OphthalmologyResearch #PatientCare #HealthcareEducation #retina #OphthalmologyFuture #medicalinnovation #glaucoma #Surgicalretina #uveitis #neuropathy COPHy Congress Simrat Sodhi Anat Loewenstein Vision Academy

Join Arthur B. Cummings, MBChB, FCS(SA), MMed(Ophth), FRCSEd, FWCRS, and Aylin Kılıç, MD, as they dive into key findings from the 2024 AECOS Europe Symposium. This insightful discussion covers patient happiness with residual refractive errors, neuroadaptation to residual astigmatism, and the promising future of allograft inlays for presbyopia and keratoconus. Discover the latest advancements and how they are shaping the future of ophthalmology. 🔗 Watch here: https://bit.ly/4biJmDj #Ophthalmology #AllograftInlays #Presbyopia #Keratoconus #AECOSEurope2024 #EyeCareInnovation

🎥 Join Dr. Peter Kaiser as he delves into the significant advancements in ophthalmic treatment with the introduction of Bayer | Ophthalmology 8 mg aflibercept. Discover how this higher dosage is making strides in patient care, allowing for extended treatment intervals and improved outcomes, especially for those with challenging cases. Dr. Kaiser shares his experiences and the promising results observed in two distinct patient groups, showcasing the drug's versatility and effectiveness. Tune in to gain valuable insights into this groundbreaking development in ophthalmology! #COPHY2024 #Aflibercept8mg #OphthalmologyInnovation #PatientCareProgress #OphthalmologyResearch #PatientCare #HealthcareEducation #retina #OphthalmologyFuture #medicalinnovation #glaucoma #Surgicalretina #uveitis #neuropathy COPHy Congress

According to the American Academy of #Ophthalmology, 20 million Americans suffer from #DryEyeDisease. John Sheppard, M.D., a dry eye specialist with #EyeCarePartners, published the results of his research on Dry Eye Disease and its association with Meibomian Gland Dysfunction in March of 2023 in Ophthalmology and Therapy. The publication recognized Dr. Sheppard's work not only as the most cited Ophthalmology and Therapy article in 2023 but also as a top-ranked article across all industry journals. As treatment protocols continue to emerge for this pervasive condition, the article provides a valuable resource to continue research in this field and is another example of how we #ElevateEyeCare together. https://lnkd.in/g-X8jYKe

@Kiawaheye covers all the topics you need, with all the excitement you want: Relevant surgical, medical, subspecialty, challenges, innovations and real-life case reviews on the hottest topics in Ophthalmology this year #Kiawaheye #ophthalmology #cme

See clearly with Dedicated IT at CSEP 2024 Regional Meeting for Ophthalmology! Explore how our simplified solutions are streamlining patient management to advanced diagnostics, we're lighting the way to a brighter future in ophthalmology. Don't blink or you'll miss out! #CSEP2024 #Ophthalmology #DedicatedIT #EyeCareInnovation

🎥 Explore the new frontier in anti-VEGF therapies with Dr. John Kitchens (RETINA ASSOCIATES OF KENTUCKY) as he compares the newer generation, including faricimab and Bayer | Ophthalmology 8 mg aflibercept, to older medications. Discover how Bayer | Ophthalmology Eylea HD (8 mg aflibercept) is revolutionizing treatment, allowing for fewer injections and extended treatment intervals, providing significant benefits for patients. Dr. Kitchens delves into the advantages of these advancements and how they're enhancing patient care in ophthalmology. Join us to learn how these innovations are changing the game! #COPHY2024 #EyleaHD #AntiVEGF #OphthalmologyInnovation #Aflibercept8mg #PatientCareProgress #OphthalmologyResearch #PatientCare #HealthcareEducation #retina #OphthalmologyFuture #medicalinnovation #Surgicalretina  COPHy Congress Simrat Sodhi